OD to OD: Remain Grounded But…
-
By
-
April Jasper, OD, FAAO
-
January 1, 2026
-
4 min
By
April Jasper, OD, FAAO
January 1, 2026
May 22, 2026
Ahead of phase 3 myopia push, late clinical-stage biopharmaceutical company takes on Thomas Ruggia as Chief Executive Officer
May 18, 2026